| 9th Dec 2016 3:05 pm |
RNS |
FDA accepts durvalumab for BLA in bladder cancer |
| 6th Dec 2016 9:30 am |
RNS |
Tagrisso data shows superiority over chemotherapy |
| 5th Dec 2016 7:00 am |
RNS |
AZ completes agreement for Rhinocort Aqua rights |
| 1st Dec 2016 4:00 pm |
RNS |
Block listing Interim Review |
| 1st Dec 2016 3:00 pm |
RNS |
Total Voting Rights |
| 22nd Nov 2016 7:00 am |
RNS |
AZ head and neck cancer trials resume enrolment |
| 17th Nov 2016 7:00 am |
RNS |
AZ out-licensing deal with Allergan completed |
| 10th Nov 2016 7:04 am |
RNS |
Year-To-Date and Q3 2016 Results |
| 9th Nov 2016 7:00 am |
RNS |
Directorate Change |
| 1st Nov 2016 3:30 pm |
RNS |
Dealing by Person Closely Associated |
| 1st Nov 2016 3:00 pm |
RNS |
Total Voting Rights |
| 31st Oct 2016 1:47 pm |
RNS |
AZ completes US Aralez agreement for Toprol-XL |
| 27th Oct 2016 4:51 pm |
RNS |
AstraZeneca Head and Neck Cancer Trials |
| 26th Oct 2016 7:00 am |
RNS |
Positive results in AstraZeneca Lynparza trial |
| 18th Oct 2016 7:00 am |
RNS |
FDA accepts for review ZS-9 NDA for hyperkalaemia |
| 7th Oct 2016 7:00 am |
RNS |
AZ DIVESTS RIGHTS TO RHINOCORT AQUA OUTSIDE US |
| 4th Oct 2016 7:05 am |
RNS |
AZ agreement with Aralez for Toprol-XL in US |
| 4th Oct 2016 7:00 am |
RNS |
AstraZeneca reports top-line EUCLID results in PAD |
| 3rd Oct 2016 3:00 pm |
RNS |
Total Voting Rights |
| 3rd Oct 2016 7:00 am |
RNS |
MedImmune out-licenses medicine to Allergan |
| 28th Sep 2016 7:00 am |
RNS |
CHANGE TO ASTRAZENECA BOARD OF DIRECTORS |
| 26th Sep 2016 4:00 pm |
RNS |
Director/PDMR Shareholding |
| 22nd Sep 2016 11:00 am |
RNS |
Director Declaration |
| 1st Sep 2016 2:30 pm |
RNS |
Total Voting Rights |
| 1st Sep 2016 7:00 am |
RNS |
AstraZeneca Completes Aspen Agreement |
| 24th Aug 2016 7:00 am |
RNS |
AZ TO SELL ANTIBIOTICS BUSINESS TO PFIZER |
| 18th Aug 2016 1:00 pm |
RNS |
Director Declaration |
| 16th Aug 2016 7:00 am |
RNS |
AstraZeneca completes agreement with LEO Pharma |
| 10th Aug 2016 2:41 pm |
RNS |
ASTRAZENECA ANNOUNCES INVESTMENT IN MODERNA |
| 9th Aug 2016 7:00 am |
RNS |
ASTRAZENECA UPDATE ON SELUMETINIB PHASE III TRIAL |
| 1st Aug 2016 2:30 pm |
RNS |
Total Voting Rights |
| 1st Aug 2016 11:00 am |
RNS |
Director/PDMR Shareholding |
| 28th Jul 2016 7:00 am |
RNS |
AZN: H1 2016 Results |
| 27th Jul 2016 9:00 am |
RNS |
Notice of Results |
| 19th Jul 2016 2:15 pm |
RNS |
QTERN (saxa/dapa) EU approved for type-2 diabetes |
| 18th Jul 2016 7:00 am |
RNS |
TAGRISSO MET PRIMARY ENDPOINT IN PHASE III TRIAL |
| 14th Jul 2016 12:07 pm |
RNS |
Second Price Monitoring Extn |
| 14th Jul 2016 12:02 pm |
RNS |
Price Monitoring Extension |
| 13th Jul 2016 7:00 am |
RNS |
AZ resolves Faslodex patent litigation in the US |
| 1st Jul 2016 5:30 pm |
RNS |
Total Voting Rights |
